ArticleScientific reports2025
Epidemiology and prognostic factors of necrotizing fasciitis in resource-limited regions based on 119 cases.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
6 citing papers in PubMed.
- Necrotizing Fasciitis of the Extremities: Microbial Spectrum, Antimicrobial Resistance, and Clinical Outcomes in a 7-Year Retrospective Cohort Study.Medicina (Kaunas, Lithuania) · 2026Article
- A Case Report of a Fulminant Necrotizing Fasciitis of the Upper Extremity in an Immunocompromised Patient.Cureus · 2026Article
- Post-operative quality of life in patients with necrotizing fasciitis: a report from a ten year institutional cohort.International orthopaedics · 2026Article
- Risk factors and predictors of in-hospital mortality in necrotizing fasciitis: a five-year retrospective cohort study from a tertiary care center in Colombia.European journal of trauma and emergency surgery : official publication of the European Trauma Society · 2026Article
- Article
- Beyond the Break: Radiologic Diagnosis and Outcomes of Necrotizing Fasciitis Complicating Orthopedic Fractures.Cureus · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Necrotizing fasciitis (NF) is a rare, life-threatening soft tissue infection with high amputation and mortality rates, often due to delayed diagnosis and treatment. This study analyzes the clinical characteristics and prognostic factors of NF to improve treatment strategies. A retrospective study was conducted on 119 NF patients treated at a tertiary hospital in Guangxi, China, from 2017 to 2023. Data on demographics, laboratory parameters, microbiology, treatments, and outcomes were collected and analyzed. Comparisons were made between survivors and non-survivors, and between patients with and without amputation. The predictive performance of the Laboratory Risk Indicator for Necrotizing Fasciitis (LRINEC) was assessed using receiver operating characteristic (ROC) curve analysis. Among 119 patients, the mean age was 56.7 years with a male-to-female ratio of 5.3:1. The lower extremities were most commonly affected (58.8%), and diabetes was prevalent (62.3%). Gram-negative bacteria were predominant (62.7%), particularly Escherichia coli (21.6%) and Klebsiella pneumoniae (19.4%), while Gram-positive bacteria were led by Staphylococcus aureus (14.9%). The overall antibiotic resistance rate was 18.7%, with Gram-negatives bacteria highly susceptible to ertapenem, imipenem, and piperacillin-tazobactam, and Gram-positives bacteria to vancomycin and levofloxacin. Amputation and in-hospital mortality rates were 16.8% and 11.8%, respectively. Risk factors for amputation encompassed lower extremity involvement, cutaneous and muscle necrosis, diabetes, elevated LRINEC scores, low RBC counts, and decreased albumin (all p < 0.05). Mortality was associated with advanced age, hypotension, coronary heart disease, hypoalbuminemia, elevated serum creatinine, uric acid, and lactate (all p < 0.05). The LRINEC score showed moderate predictive power for amputation (AUC = 0.726, cutoff = 8) but limited utility for mortality prediction (AUC = 0.592). NF predominantly affects middle-aged and elderly males, with diabetes as a common underlying condition. Early surgical intervention and empirical use of carbapenems combined with vancomycin are recommended for infection control. Enhancing early treatment effectiveness and optimizing disease management are key to improving patient outcomes in resource-limited settings.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.